Oncology Clinical Research

Oncology research has a wide range, and the complexity of clinical trial and study designs is increasing. According to statistics, cancer currently has the lowest success rate of experimental compounds approved for clinical usage among all diseases, and the possibility that oncology medications examined in Phase I trials would be approved is only 6.7%. In oncology, clinical trials differ significantly from one another. The distinctions are better appreciated to maximize the utilization of scarce resources and the influence of cancer research on clinical practise.

  • Cancer subtypes
  • Creation of oncology study data
  • Systematic evaluation

Related Conference of Oncology Clinical Research

February 24-25, 2025

2nd International Conference on Pharmacognosy

Madrid, Spain
February 27-28, 2025

8th International on Pharmacy and Pharmaceutical Conference

Prague, Czech Republic
March 10-11, 2025

35th Annual European Pharma Congress

Rome, Italy
April 14-15, 2025

18th European Biosimilars Congress

Paris, France
April 24-25, 2025

18th World Drug Delivery Summit

London, UK
May 05-06, 2025

19th World Drug Delivery Summit

Vancouver, Canada
June 16-17, 2025

3rd Global Online Summit on Nanoscience and Nanotechnology

Zurich, Switzerland
June 23-24, 2025

38th World Congress on Pharmacology

Aix-en-Provence, France
September 23-24, 2025

10th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland

Oncology Clinical Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in